Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-30

FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for a fixed-dose combination of amlodipine and atorvastatin, manufactured by Prasco Laboratories, enabling a generic ver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Atorvastatin Calcium (amlodipine besylate and atorvastatin calcium)

Snippet

SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)